"It can affect whether they seek care, whether they talk openly with providers and how they manage their health overall." Though GLP-1s have often been described as a boon to managing obesity rate in the U.S., the idea that they are an "easy way out" persists, said Standen and fellow study authors Sean Phelan, professor of health services research at the Mayo Clinic, and Janet Tomiyama, professor of psychology at the University of California, Los Angeles
Those averages came from a specific population
Since then, more than ten types of GLP-1 receptor agonists have received FDA approval and been brought to market, and with each new version, their effectiveness has increased
As a new hypoglycemic drug, GLP-1RA has a unique role in reducing the concurrent risk of stroke in T2D patients
Redox Signal 22 , 731743 (2015)